Sharps Technology, Inc. (STSS) 10-Year Financial Performance & Capital Metrics

STSS • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesSafety Syringes & Injectables

AboutSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.Show more

Revenue $0
EBITDA -$7M +23.3%
Net Income -$9M +5.5%
EPS (Diluted) -2220.05 -782.0%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -187.23% -67.2%
ROIC -120.05% +17.9%
Debt/Equity 1.89
Interest Coverage -4.61

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 89.3% through buybacks
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Weak momentum: RS Rating 3 (bottom 3%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM91.19%

EPS CAGR

10Y-

5Y-

3Y-

TTM-589.98%

ROCE

10Y Avg-185.44%

5Y Avg-149.11%

3Y Avg-133.8%

Latest-153.69%

Peer Comparison

Safety Syringes & Injectables

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UTMDUtah Medical Products, Inc.	193.09M	60.27	15.22	-18.56%	32.33%	10.68%	7.56%	0.00
STSSSharps Technology, Inc.	66.69M	2.30	-0.00		-324.78%	-4.98%		1.89
RVPRetractable Technologies, Inc.	21.26M	0.71	-1.78	-24.19%	-22.9%	-11.43%		0.01
XRAYDENTSPLY SIRONA Inc.	2.51B	12.58	-2.81	-4.34%	-24.34%	-59.68%	11.19%	1.17
ZTEKZentek Ltd.	93.36M	0.87	-8.70	28.26%	-8.95%	-70.13%		0.05

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-
Cost of Goods Sold+	10.59K	11.04K	28.7K	654.57K	891.25K	773.9K
COGS % of Revenue	-	-	-	-	-	-
Gross Profit+	-10.59K	-11.04K	-28.7K	-654.57K	-891.25K	-773.9K
Gross Margin %	-	-	-	-	-	-
Gross Profit Growth %	-	-0.04%	-1.6%	-21.81%	-0.36%	0.13%
Operating Expenses+	2.05M	2.32M	4.47M	8.08M	9.24M	7.08M
OpEx % of Revenue	-	-	-	-	-	-
Selling, General & Admin	1.66M	1.51M	2.78M	6.45M	8.52M	7.14M
SG&A % of Revenue	-	-	-	-	-	-
Research & Development	388.02K	827K	1.69M	1.63M	729.48K	-58.02K
R&D % of Revenue	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	-15.18K	0
Operating Income+	-2.06M	-2.33M	-4.5M	-8.74M	-10.13M	-7.86M
Operating Margin %	-	-	-	-	-	-
Operating Income Growth %	-	-0.13%	-0.93%	-0.94%	-0.16%	0.22%
EBITDA+	-2.05M	-2.32M	-4.47M	-8.08M	-9.24M	-7.08M
EBITDA Margin %	-	-	-	-	-	-
EBITDA Growth %	-	-0.13%	-0.92%	-0.81%	-0.14%	0.23%
D&A (Non-Cash Add-back)	10.59K	11.04K	28.7K	654.57K	891.25K	773.9K
EBIT	-2.06M	-2.34M	-4.5M	-3.32M	-9.87M	-7.62M
Net Interest Income+	3.6K	3.33K	-166.75K	-1.32M	138.12K	-1.66M
Interest Income	3.6K	3.33K	769	1.32K	138.12K	40.3K
Interest Expense	0	0	167.51K	1.32M	0	1.71M
Other Income/Expense	3.6K	-6.87K	-166.75K	4.1M	255.01K	-1.47M
Pretax Income+	-2.06M	-2.34M	-4.66M	-4.64M	-9.87M	-9.33M
Pretax Margin %	-	-	-	-	-	-
Income Tax+	0	0	0	0	-30K	-30K
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-2.06M	-2.35M	-4.66M	-4.64M	-9.84M	-9.3M
Net Margin %	-	-	-	-	-	-
Net Income Growth %	-	-0.14%	-0.99%	0.01%	-1.12%	0.06%
Net Income (Continuing)	-2.06M	-2.34M	-4.66M	-4.64M	-9.84M	-9.3M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-102.05	-167.14	-175.57	-0.57	-251.72	-2220.05
EPS Growth %	-	-0.64%	-0.05%	1%	-440.61%	-7.82%
EPS (Basic)	-102.06	-167.14	-175.57	28.89	-251.73	-2220.05
Diluted Shares Outstanding	20.14K	14.04K	27.52K	24.3K	39.1K	4.19K
Basic Shares Outstanding	20.14K	14.04K	27.52K	24.3K	39.1K	4.19K
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	635.5K	1.84M	1.61M	4.42M	4.84M	3.17M
Cash & Short-Term Investments	635.5K	1.79M	1.48M	4.17M	3.01M	864.04K
Cash Only	635.5K	1.79M	1.48M	4.17M	3.01M	864.04K
Short-Term Investments	0	0	0	0	0	0
Accounts Receivable	0	0	0	0	47.95K	102.49K
Days Sales Outstanding	-	-	-	-	-	-
Inventory	0	0	121.99K	185.8K	1.71M	1.87M
Days Inventory Outstanding	-	-	1.55K	103.61	699.96	880.86
Other Current Assets	0	0	0	0	0	250K
Total Non-Current Assets+	25.9K	391.87K	4.29M	7.42M	6.95M	4.14M
Property, Plant & Equipment	25.9K	316.87K	3.76M	7.34M	6.82M	4.04M
Fixed Asset Turnover	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0
Intangible Assets	0	0	0	62.48K	52.51K	32.5K
Long-Term Investments	0	0	0	0	0	0
Other Non-Current Assets	0	75K	529.86K	12.37K	76.06K	72.2K
Total Assets+	661.4K	2.23M	5.9M	11.84M	11.79M	7.31M
Asset Turnover	-	-	-	-	-	-
Asset Growth %	-	2.37%	1.64%	1.01%	-0%	-0.38%
Total Current Liabilities+	100.49K	101.25K	2.77M	2.01M	3.69M	5.19M
Accounts Payable	100.49K	101.25K	804.14K	543.23K	794.11K	976.55K
Days Payables Outstanding	3.46K	3.35K	10.23K	302.91	325.22	460.57
Short-Term Debt	0	0	700.01K	0	0	3.76M
Deferred Revenue (Current)	0	0	0	0	0	0
Other Current Liabilities	0	0	585K	1.15M	2.42M	98.91K
Current Ratio	6.32x	18.18x	0.58x	2.20x	1.31x	0.61x
Quick Ratio	6.32x	18.18x	0.54x	2.11x	0.85x	0.25x
Cash Conversion Cycle	-	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	192K	162K	132K
Long-Term Debt	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	192K	162K	132K
Other Non-Current Liabilities	0	0	0	0	0	0
Total Liabilities	100.49K	101.25K	2.77M	2.2M	3.85M	5.32M
Total Debt+	0	0	700.01K	0	0	3.76M
Net Debt	-635.5K	-1.79M	-779.15K	-4.17M	-3.01M	2.9M
Debt / Equity	-	-	0.22x	-	-	1.89x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-	-26.85x	-6.62x	-	-4.61x
Total Equity+	560.92K	2.13M	3.14M	9.64M	7.93M	2M
Equity Growth %	-	2.8%	0.47%	2.07%	-0.18%	-0.75%
Book Value per Share	27.85	151.74	113.97	396.74	202.93	476.74
Total Shareholders' Equity	560.92K	2.13M	3.14M	9.64M	7.93M	2M
Common Stock	1.38K	460	519	941	1.53K	205
Retained Earnings	-3.66M	-6M	-10.67M	-15.31M	-25.15M	-34.45M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	0	214.25K	591.81K	23.29K
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.57M	-1.88M	-3.15M	-6.43M	-8.51M	-6.93M
Operating CF Margin %	-	-	-	-	-	-
Operating CF Growth %	-	-0.2%	-0.67%	-1.04%	-0.32%	0.19%
Net Income	-2.06M	-2.34M	-4.66M	-4.64M	-9.84M	-9.3M
Depreciation & Amortization	10.59K	11.04K	28.7K	654.57K	882.18K	773.9K
Stock-Based Compensation	400	485.2K	1.2M	1.01M	963.02K	520.83K
Deferred Taxes	25.84K	0	0	0	-30K	-30K
Other Non-Cash Items	372.57K	10.2K	179.51K	-3.25M	639.99K	1.53M
Working Capital Changes	72.42K	-49.24K	112.64K	-209.22K	-1.12M	-426.18K
Change in Receivables	0	0	0	0	0	0
Change in Inventory	0	0	-121.99K	-34.11K	-1.44M	-350.56K
Change in Payables	47.42K	759	202.89K	-104.35K	415.51K	11.94K
Cash from Investing+	-11.18K	-387.2K	-2.34M	-3.12M	-698.28K	-1.16M
Capital Expenditures	-11.18K	-312.2K	-2.27M	-752.34K	-698.28K	-138.8K
CapEx % of Revenue	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	0	-75K	-75K	-2.16M	0	-1.02M
Cash from Financing+	1.83M	3.42M	5.18M	12.24M	8.03M	5.91M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	180K	0	0	32.5K	0	0
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-1.58M	-2.2M	-5.42M	-7.19M	-9.21M	-7.07M
FCF Margin %	-	-	-	-	-	-
FCF Growth %	-	-0.39%	-1.47%	-0.33%	-0.28%	0.23%
FCF per Share	-78.69	-156.33	-196.84	-295.69	-235.45	-1688.17
FCF Conversion (FCF/Net Income)	0.77x	0.80x	0.67x	1.39x	0.86x	0.75x
Interest Paid	0	0	0	0	0	0
Taxes Paid	0	1.13K	0	0	0	0

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-366.46%	-174.4%	-177.12%	-72.62%	-111.99%	-187.23%
Return on Invested Capital (ROIC)	-	-1315.65%	-250.09%	-167.47%	-146.18%	-120.05%
Debt / Equity	-	-	0.22x	-	-	1.89x
Interest Coverage	-	-	-26.85x	-6.62x	-	-4.61x
FCF Conversion	0.77x	0.80x	0.67x	1.39x	0.86x	0.75x

Frequently Asked Questions

Growth & Financials

Sharps Technology, Inc. (STSS) reported $0.2M in revenue for fiscal year 2024.

Sharps Technology, Inc. (STSS) grew revenue by 0.0% over the past year. Growth has been modest.

Sharps Technology, Inc. (STSS) reported a net loss of $0.7M for fiscal year 2024.

Dividend & Returns

Sharps Technology, Inc. (STSS) has a return on equity (ROE) of -187.2%. Negative ROE indicates the company is unprofitable.

Sharps Technology, Inc. (STSS) had negative free cash flow of $9.8M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener